Dr. Francis Zirille, mentee, presenting our data on Lp(a) at AHA Chicago yesterday

This landmark article by Drs. Rebecca Hahn has made a game changing impact on treatment of pts. with TR. I will discuss it more in my talk tomorrow. International Society of CV Ultrasound.

⁦National Lipid Association⁩ #NLASessions Dr Marlys Koschinsky updating us with all the Lp(a) lowering trials. Note the currently unpublished figure!

⁦National Lipid Association⁩ #NLASessions Dr Daniel Gaudet bringing us up to date with apoC3

⁦National Lipid Association⁩ #NLASessions The team discussion for LDL lowering and CETP inhibition

⁦National Lipid Association⁩ #NLASessions President Christie Ballantyne teaching us about CETP inhibitors

⁦National Lipid Association⁩ #NLASessions Professor Ray schooling us on CETP inhibition and in this case how much CETPi lowers Lp(a)

⁦National Lipid Association⁩ #NLASessions Dr. Gaudet discussing how Apo C3 inhibition or gain of function affects triglycerides levels

⁦⁦⁦⁦⁦National Lipid Association⁩ #NLASessions Dr. Michael Boffa showing the structure of Lp(a) and previewing electron microscopy viewing

⁦National Lipid Association⁩ #NLASessions Now this is a multidisciplinary team! Emphasis on FCS

⁦National Lipid Association⁩ #NLASessions Allen Taylor and Melissa Wood discussing CCTA evaluation of@plaque

⁦National Lipid Association⁩ #NLASessions Dr Allen Taylor and Dr Melissa Wood discussing AI evaluation of plaque. Note the difference in out come if you have more than 4% low attenuation plaque!!!!!🥸

⁦National Lipid Association⁩ #NLASessions note the difference in those treated with statin +PCSK9 versus statin alone

⁦National Lipid Association⁩ #NLASessions Is Lp(a) associated with higher risk plaque? Yes!

⁦⁦National Lipid Association⁩ #NLASessions a new paradigm? Atherosclerosis based on stage

⁦National Lipid Association⁩ @NLASessions Amazing turnout to hear about CCTA AI assessment of plaque

⁦National Lipid Association⁩ #NLASessions Dr. Anand Rohatgi discussing the benefits (or detriments???) of HDL

⁦National Lipid Association⁩ #NLASessions Dr Danesh Kalra once again breaking down atherosclerosis by stage using CCTA

Washington men row to program's 21st national title seattletimes.com/sports/uw-husk… Go UW Huskies

⁦National Lipid Association⁩ #NLASessions Dr. Kalra discussing his ARTCAP trial of ACC guideline treatment versus more intensive lipid lowering plus colchicine followed by MACE and plaque analysis